Direct Biologics

World IBD Day is dedicated to raising awareness of inflammatory bowel diseases. We’re committed to developing naturally regenerative therapies for these diseases. directbiologics.com​ #WorldIBDDay #ibdawareness #crohns #crohnsdisease #ulcerativecolitis #regenerativemedicine

Happy Mother’s Day to all the amazing moms out there! Thank you for all you do! directbiologics.com #happymothersday2023 #moms #MotherDay #loveyoumom #family

On International Nurses Day, we would like to recognize and honor all nurses. We’re especially thankful for our own nurses at Direct Biologics, Alexandria VanDenBossche, Ashley Adams and Anita Barnoski. You are appreciated! #IND2023 #healthcareheroes #InternationalNursesDay

Exosomes were first described in two papers published within a week of each other 40 years ago. One, co-authored by Dr. Rose Mamelak Johnstone, PhD. paved the way for our extracellular vesicle (EV)-based regenerative medicine platform. #regenerativemedicine

Direct Biologics has gained clearance for another first-of-its-kind Clinical Trial! tinyurl.com/mr4dcnsf #drugdiscovery #innovation #biotech #crohnsdisease

This National Donate Life Month, we want to recognize and honor those who have given the gift of life through organ, eye, and tissue donations. Organ donation has the power to impact countless lives. #DonateLifeMonth #MakeASplash #OrganDonation #SaveLives

Another major milestone for the team at Direct Biologics! tinyurl.com/8nukkx4b

Our therapeutic platform in development is based on immunomodulatory and regenerative capabilities of extracellular vesicles (EVs) and the body's natural ability to heal itself. directbiologics.com

Marking a defining moment for regenerative medicine, the FDA has authorized the expansion of our pivotal Phase 3 clinical trial to include all-cause ARDS. tinyurl.com/4y9zdjfp #ARDS #Innovation

This #NationalPhysiciansWeek, we to thank the #doctors, #nurses, and #healthcare providers who helped us navigate the Covid-19 pandemic. More than ever, they deserve our appreciation and respect.

We’ve reached an important milestone in our clinical trial program for IBD: the first patient has been dosed in a Phase 1 clinical trial evaluating ExoFlo™ for the treatment of medically refractory #UlcerativeColitis. bit.ly/40yd0zE #DrugDevelopment #Biotech #Crohns

Kidneys remove toxins from our bodies, make hormones, and perform other life-sustaining tasks. Not everyone’s are in working order. We’re committed to developing regenerative therapies that improve outcomes for kidney transplant patients. #NationalKidneyMonth #organcare

The Phase 1 clinical trial of our investigational biologic, ExoFlo™, in medically refractory #CrohnsDisease is officially underway with the first patient dosed via IV administration. bit.ly/405zSGS #DrugDevelopment #Biotech

Extracellular vesicles (EVs) stimulate anti-inflammatory, immunomodulatory, and restorative pathways. They are the foundation of the newest generation of naturally bioactive products and regenerative therapies in development. directbiologics.com #biotech

We’re pleased to announce favorable safety, dosing and efficacy results from our Phase 2 clinical trial of ExoFlo™, our experimental extracellular vesicle (EV)-based regenerative medicine, in #Covid-19 patients. bit.ly/3FiXC1F #DrugDevelopment #Biotech #ARDS

On #NationalCOVID19Day we reflect on the lives lost or altered by the pandemic. It is also a day for hope! We’re working to create new #technologies to treat respiratory failure due to Covid-19. Learn more: directbiologics.com/exoflo/ #COVID19Day

Happy International Women’s Day! As biotech innovators, we value diversity, equality, respect, and inclusion at every level. #InternationalWomensDay #WomenInStem #WomenInScience

Hearty congratulations to our very own Tim Moseley, PhD, on his promotion to Chief Technology Officer. We’re proud to have you on our team! #leadership #biotechnews

We are defining the next generation of regenerative medicine with our novel pipeline of extracellular vesicle (EV) technologies. directbiologics.com #DrugDevelopment #RegenerativeMedicine